The differences between PFSs and MDVs (per 1000 doses) is 324.21. MDV: Multidose vial; NA: Not available; PFS: Prefilled syringe. Prefilled syringes (PFSs) have gained market share in the USA ...

In seventh place and up three spots is Eli Lilly and Boehringer Ingelheim’s diabetes drug Jardiance, while GSK’s RSV vaccine Arexvy is down in eighth position, a fall of two spots despite the ...

In its Q3 results, GSK (NYSE:GSK), the first to receive U.S. approval for an RSV vaccine in May 2023, said its Arexvy vaccine added £188M in sales, indicating ~ a 73% YoY drop. The British ...

In June, the FDA expanded the approval of GSK's RSV vaccine (Arexvy) to include adults ages 50-59 at increased risk of lower respiratory tract disease due to underlying chronic conditions.

GSK has claimed a new approval for its respiratory syncytial virus (RSV) vaccine Arexvy, currently locked in a battle for market share with rival shots from Pfizer and Moderna, that could lend it ...

The vaccine for this population is usually AREXVY. Receiving your vaccine doesn’t only help you, it helps the people around you stay healthy as well. “You know, I always say that an ounce of ...

Moderna said on Friday that Canada’s health regulator has approved its vaccine for respiratory syncytial virus (RSV) in adults 60 years and older, making it the country’s first authorized mRNA ...

GSK's Arexvy and Pfizer (PFE.N), opens new tab's shot Abrysvo, both protein-based vaccines, are also approved in Canada for adults aged 60 years and older. Moderna's shot was approved in the ...